SK bioscience and Sanofi have announced plans for global Phase III studies, which will assess the safety and immunogenicity ...

Repair Biotechnologies, Inc. ( a biotechnology company developing first-in-class therapies capable of rapidly reducing atherosclerotic plaque, is pleased to announce that it has ...

SYRACUSE, NEW YORK / ACCESS Newswire / January 21, 2025 / Repair Biotechnologies, Inc. ( a biotechnology company developing first-in-class therapies capable of rapidly reducing atherosclerotic plaque, ...

Atara Biotherapeutics said the U.S. Food and Drug Administration placed a clinical hold on its active investigational new drug applications.

The FDA placed a clinical hold on two Atara assets, following an inspection at a third-party site that also led to a CRL for ...

IPH4502 is a novel and differentiated topoisomerase I inhibitor ADC designed to precisely target Nectin-4, a cell adhesion ...

A 14-year-old male has been charged with attempted rape, reckless homicide and several other felonies in connection to an ...

Neuraly and Enigma Biomedical have signed an agreement for PMI04, a positron emission tomography (PET) imaging biomarker for ...

The president ordered the withdrawal of the country from the Paris climate agreement and took action on immigration policy ...

Investment company RTW Investments has launched a new biotech company called Prolium Bioscience, to advance the development ...

Shionogi’s S-892216 is being developed as a pre-exposure prophylaxis (PrEP) drug for Covid-19. Credit: seksan Mongkhonkhamsao ...